IBM’s stock has faced significant pressure in recent months, shedding over 20% from its 52-week high since the start of the year. This decline was triggered by a specific market development: AI firm Anthropic announced it had identified COBOL modernization as a new application for its technology. This strikes at the heart of a domain where IBM has long been considered an indispensable partner for major corporations.
The core concern for investors is clear. If artificial intelligence models become capable of independently modernizing legacy code, a fundamental pillar of IBM’s consulting business could come under threat. This potential disruption has understandably prompted a nervous reaction from institutional holders.
A Divided Institutional Landscape
The institutional investment picture reveals a split in sentiment. During the fourth quarter of 2025, data shows 1,672 investors increased their holdings in IBM, while 1,529 reduced their positions. Notable moves included UBS Asset Management divesting approximately 19.8 million shares, a reduction of 73%. On the opposing side, T. Rowe Price aggressively expanded its stake by 83%, and Capital World Investors added roughly 5 million shares to its portfolio.
Wall Street’s Constructive Stance Persists
Despite the share price weakness, the majority of market analysts maintain a positive outlook. Following direct discussions with company management, Bank of America Securities reaffirmed its Buy rating on March 10. Although Morgan Stanley adjusted its price target downward from $304 to $247, the overall consensus among the 13 analysts covering IBM remains around $319, which sits well above the current trading level. The spectrum of price targets is broad, with the lowest at $236 and the most bullish reaching $370.
Should investors sell immediately? Or is it worth buying IBM?
Counterweights: Cybersecurity Demand and Quantum Ambition
Beyond the AI debate, IBM’s recent X-Force Threat Intelligence Index provides a compelling case for the structural growth in enterprise security. The report documented a 44% year-over-year increase in attacks targeting publicly accessible applications and a 49% rise in active ransomware groups. Furthermore, vulnerability exploits were responsible for 40% of all incidents observed by X-Force in 2025. These trends directly support sustained demand for IBM’s comprehensive security portfolio.
Looking further ahead, the company is making a substantial long-term bet on quantum computing. IBM has announced plans to launch its first large-scale, fault-tolerant quantum computer by 2029. The realization of this goal would have transformative implications reaching far beyond the technology sector itself.
Structural Resilience Versus Short-Term Pressure
IBM’s current situation reflects a tension experienced by many established technology firms: fears of AI-driven disruption are colliding with a deeply entrenched client base and a diversified service offering. It is noteworthy that, despite the recent pullback, the stock has still appreciated more than 100% over the preceding five-year period. The prevailing analyst consensus continues to recommend buying the shares. With its cybersecurity division and quantum computing strategy, IBM possesses two segments positioned for structural growth, largely independent of the prevailing sentiment surrounding artificial intelligence.
Ad
IBM Stock: Buy or Sell?! New IBM Analysis from March 16 delivers the answer:
The latest IBM figures speak for themselves: Urgent action needed for IBM investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 16.
IBM: Buy or sell? Read more here...









